-
3m 51sPart 1 | Session 3 3 Ways AI Will Change Your Practice
-
21m 50sPart 1 | Session 4 TCT 25 Structural Interventions Highlights
-
5m 33sPart 2 | Session 1 SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
-
5m 49s
-
20m 17sPart 2 | Session 4 TRILUMINATE Pivotal Trial: Lessons Learned from Tricuspid TEER
-
10m 9sPart 2 | Session 5 Real-World EVOQUE Outcomes from TVT Registry
-
8m 6sPart 2 | Session 6 PASCAL Precision System in Complex Degenerative MR
-
7m 2sPart 2 | Session 7 PREVUE-VALVE: Prevalence of Valvular Heart Disease in Older Americans
-
7m 4s
-
6m 55sPart 2 | Session 9 Short-CUT: Lithotripsy Vs Cutting Balloon for CAD
-
4m 10sPart 2 | Session 10 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
-
28m 2sPart 2 | Session 11 1-Year ENCIRCLE TMVR Results with SAPIEN M3
-
10m 32s
-
14m 58s
-
6m 49sPart 1 | Session 1 5 Trials That Will Change My Practice with Dr Mirvat Alasnag
TCT 2025 - In this comprehensive highlights video from TCT 2025, Prof Rasha Al-Lamee (Imperial College Healthcare NHS Trust, UK) delivers an expert analysis of the groundbreaking late-breaking trials that are set to reshape interventional cardiology practice.
Join Prof Al-Lamee as she breaks down the pivotal studies driving innovation in cardiovascular care and discusses their implications for improving patient outcomes in real-world clinical settings.
Key Trials Covered Include:
0:33: The SELUTION DeNovo Trial
0:56: PROCTOR
Editor: Jordan Rance.
Videographer: Tom Green and Oliver Miles.
Support: This is an independent video produced by Radcliffe Cardiology.
Stay Updated with Our TCT 2025 Video Coverage
We’re bringing you independent, critical insights straight from TCT 2025.
Join Prof Nicolas Van Mieghem in Cardiology Conference Perspectives as he discusses what the late-breaking data could mean for your practice.
Don’t miss our short Expert Interviews with investigators, offering concise analyses and practical take-home messages.
Hear Dr Mirvat Alasnag and Dr Rasha Al-Lamee share their views on the data they believe will have the greatest impact on clinical practice.
Follow the hot topics driving innovation in interventional cardiology, and stay tuned for fresh perspectives, real-world insights and global viewpoints, all coming soon on Transcatheter Academy.
More from this programme
Part 1
Highlights
Part 2
Expert Interviews
Part 3
NVM Cardiology Conference Perspectives
A focused video series where Prof Nicolas Van Mieghem offers expert reflections on the most impactful late-breaking trials shaping interventional cardiology at TCT 2025.
Faculty Biographies
Rasha Al-Lamee
Interventional Cardiology Consultant
Dr Rasha Al-Lamee is an interventional cardiology consultant at Imperial College Healthcare NHS Trust, London, UK.
Dr Al-Lamee studied at the University of Oxford and University College London. She completed her training in clinical cardiology on the north-west London cardiology rotation in 2013, and completed her PhD at Imperial College London in 2018.
Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is lead author of the primary publication in The Lancet. Dr Al-Lamee has more than 50 peer-reviewed publications and has presented at international cardiology conferences worldwide.
Comments